What Is Semaglutide?
Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone secreted by the gut in response to food intake. As a GLP-1 receptor agonist, semaglutide mimics the action of this hormone with a significantly extended half-life, making it one of the most studied peptides in modern metabolic science.
Mechanism of Action
Semaglutide binds to GLP-1 receptors found throughout the body — including the pancreas, brain, heart, and gut. Its key actions include stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite via central nervous system pathways.
What Research Shows
Clinical research on semaglutide has produced some of the most compelling data in metabolic peptide science. Key findings include significant reductions in body weight, improvements in HbA1c levels, reductions in cardiovascular risk markers, and improvements in liver fat content in subjects with non-alcoholic fatty liver disease.
Research Applications
- Metabolic syndrome and obesity research
- Type 2 diabetes and insulin resistance studies
- Cardiovascular risk reduction research
- Non-alcoholic fatty liver disease (NAFLD) investigation
- Appetite regulation and neuroendocrinology
Freeze-Dried Format
Our Semaglutide is available in lyophilised (freeze-dried) powder form, the gold standard for peptide preservation.
Important Disclaimer
This compound is intended strictly for research purposes only. It is not approved for human consumption and is not intended to diagnose, treat, cure, or prevent any disease.
🛒 Shop This Compound
Semaglutide is available as part of our Metabo GLP-3 Peptide collection at SONOCOUTURE.